Home > Publications database > CD8+ T cells variably recognize native versus citrullinated GRP78 epitopes in type 1 diabetes. > print

001     176904
005     20240229133723.0
024 7 _ |a 10.2337/db21-0259
|2 doi
024 7 _ |a pmid:34561224
|2 pmid
024 7 _ |a 0012-1797
|2 ISSN
024 7 _ |a 1939-327X
|2 ISSN
024 7 _ |a altmetric:114003580
|2 altmetric
037 _ _ |a DKFZ-2021-02146
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Azoury, Marie Eliane
|b 0
245 _ _ |a CD8+ T cells variably recognize native versus citrullinated GRP78 epitopes in type 1 diabetes.
260 _ _ |a Alexandria, Va
|c 2021
|b Assoc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1655805828_29664
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Deutsches Krebsforschungszentrum (DKFZ), Division of Developmental Immunology, 69120 Heidelberg, Germany., 2021 Dec;70(12):2879-2891
520 _ _ |a In type 1 diabetes, autoimmune β-cell destruction may be favored by neo-antigens harboring post-translational modifications such as citrullination. We studied the recognition of native and citrullinated glucose-regulated protein (GRP)78 peptides by CD8+ T cells. Citrullination modulated T-cell recognition and, to a lesser extent, HLA-A2 binding. GRP78-reactive CD8+ T cells circulated at similar frequencies in type 1 diabetic and healthy donors and preferentially recognized either native or citrullinated versions, without cross-reactivity. Rather, the preference for native GRP78 epitopes was associated with CD8+ T cells cross-reactive with bacterial mimotopes. In the pancreas, a dominant GRP78 peptide was instead preferentially recognized when citrullinated. To further clarify these recognition patterns, we considered the possibility of citrullination in the thymus. Citrullinating peptidyl-arginine deiminase (Padi) enzymes were expressed in murine and human medullary epithelial cells (mTECs), with citrullinated proteins detected in murine mTECs. However, Padi2 and Padi4 expression was diminished in mature mTECs from NOD mice versus C57BL/6 mice. We conclude that, on one hand, the CD8+ T-cell preference for native GRP78 peptides may be shaped by cross-reactivity with bacterial mimotopes. On the other hand, post-translational modifications may not invariably favor loss of tolerance because thymic citrullination, although impaired in NOD mice, may drive deletion of citrulline-reactive T cells.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Samassa, Fatoumata
|b 1
700 1 _ |a Buitinga, Mijke
|b 2
700 1 _ |a Nigi, Laura
|b 3
700 1 _ |a Brusco, Noemi
|b 4
700 1 _ |a Callebaut, Aïsha
|b 5
700 1 _ |a Giraud, Matthieu
|b 6
700 1 _ |a Irla, Magali
|b 7
700 1 _ |a Lalanne, Ana Ines
|b 8
700 1 _ |a Carré, Alexia
|b 9
700 1 _ |a Afonso, Georgia
|b 10
700 1 _ |a Zhou, Zhicheng
|b 11
700 1 _ |a Brandao, Barbara
|b 12
700 1 _ |a Colli, Maikel L
|b 13
700 1 _ |a Sebastiani, Guido
|b 14
700 1 _ |a Dotta, Francesco
|b 15
700 1 _ |a Nakayama, Maki
|b 16
700 1 _ |a Eizirik, Decio L
|b 17
700 1 _ |a You, Sylvaine
|b 18
700 1 _ |a Pinto, Sheena
|0 P:(DE-He78)d2f9dbffa7b9a979f9bc4d81e769497e
|b 19
700 1 _ |a Mamula, Mark J
|b 20
700 1 _ |a Verdier, Yann
|b 21
700 1 _ |a Vinh, Joelle
|b 22
700 1 _ |a Buus, Soren
|b 23
700 1 _ |a Mathieu, Chantal
|b 24
700 1 _ |a Overbergh, Lut
|b 25
700 1 _ |a Mallone, Roberto
|b 26
773 _ _ |a 10.2337/db21-0259
|g p. db210259 -
|0 PERI:(DE-600)1501252-9
|n 12
|p 2879-2891
|t Diabetes
|v 70
|y 2021
|x 1939-327X
909 C O |p VDB
|o oai:inrepo02.dkfz.de:176904
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)d2f9dbffa7b9a979f9bc4d81e769497e
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-01-27
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b DIABETES : 2019
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-01-27
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-01-27
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b DIABETES : 2019
|d 2021-01-27
920 1 _ |0 I:(DE-He78)D090-20160331
|k D090 ; D090
|l Entwicklungsimmunologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D090-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21